Open the map

Bristol Myers SquibbBMY

Big pharma · NYSE · USA

$59.58
Down 0.2% todayClose

Up 10.7% this year and +3.6% since June 26, behind the life science sector at +10.7%. Bristol Myers Squibb supplies 2 mapped companies and buys from 3.

Market cap
$121B
This year
+10.7%
1 year
+33.7%
P/E
13.0
P/S
2.5
P/B
5.4

Price vs the life science sector

since Jun 26BMYLife science sector, equal weight
Bristol Myers Squibb (BMY) vs the Life science sector indexDaily closes from Jun 26, 2026 to Oct 8, 2026, each line rebased to its own first value. BMY: +3.6% from Jun 26, 2026 to Oct 8, 2026. Life science sector index: +10.7% from Jun 26, 2026 to Oct 8, 2026.0%+5%+10%+15%Jun 26AugSepOct 8BMY +3.6%Sector +10.7% Bristol Myers Squibb (BMY) vs the Life science sector indexDaily closes from Jun 26, 2026 to Oct 8, 2026, each line rebased to its own first value. BMY: +3.6% from Jun 26, 2026 to Oct 8, 2026. Life science sector index: +10.7% from Jun 26, 2026 to Oct 8, 2026.0%+5%+10%+15%Jun 26AugSepOct 8BMY+3.6%Sector+10.7%

Supply chain

3 suppliers · 2 customers
SUPPLIERS →→ CUSTOMERSRevvity (RVTY)RVTYRevvity−0.9%Charles River Laboratories (CRL)CRLCharles River Labor…−0.8%West Pharmaceutical Services (WST)WSTWest Pharmaceutical…−0.9%McKesson (MCK)MCKMcKesson+2.2%Cencora (COR)CORCencora+1.3%BMYBristol Myers S…

Suppliers 3

Customers 2

Open the full chain →

About Bristol Myers Squibb

Opdivo made the company's name in oncology. Immunology and haematology fill out the portfolio, with neuroscience coming through the pipeline.

Theme exposure

Big pharmaOncologyImmunology

Products

  • Oncology (Opdivo)
  • Immunology
  • Hematology

Competitors

Risks

  • Patent cliff (Eliquis, Opdivo)
  • Pipeline transition

Same segment: Big pharma

Large, diversified pharmaceutical groups with broad portfolios across therapeutic areas. Segment 2 of 8 in the Medicine, pharma & life science value chain.

Johnson & JohnsonJNJ−0.8%AbbVieABBV+0.4%Merck & Co.MRK−0.3%PfizerPFE−0.6%ZoetisZTS+2.1%

Compare BMY

Side by side with the largest companies in the same segment.

BMY vs JNJBMY vs ABBVBMY vs MRKBMY vs PFEBMY vs ZTS

See where Bristol Myers Squibb sits in the full Medicine, pharma & life science map: every segment from upstream suppliers to end markets, with daily metrics.

Open the Life science value chain →